Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 776

Similar articles for PubMed (Select 11986486)

1.

Influenza vaccination coverage level at a cystic fibrosis center.

Marshall BC, Henshaw C, Evans DA, Bleyl K, Alder S, Liou TG.

Pediatrics. 2002 May;109(5):E80-0.

PMID:
11986486
2.
3.

Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.

Rosenthal J, Rodewald L, McCauley M, Berman S, Irigoyen M, Sawyer M, Yusuf H, Davis R, Kalton G.

Pediatrics. 2004 Apr;113(4):e296-302.

PMID:
15060256
5.

Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP.

Pediatrics. 2005 Sep;116(3):e397-407.

6.

Influenza vaccination coverage in patients with cystic fibrosis followed at 12 care centers in the Greater South Region of France for the season 2005/2006.

Murris-Espin M, Aubert M, Bosdure E, Dubus JC.

Vaccine. 2008 Oct 16;26(44):5612-8. doi: 10.1016/j.vaccine.2008.07.095. Epub 2008 Aug 20.

PMID:
18721838
8.
9.

Standing orders for influenza vaccination increased vaccination rates in inpatient settings compared with community rates.

Lawson F, Baker V, Au D, McElhaney JE.

J Gerontol A Biol Sci Med Sci. 2000 Sep;55(9):M522-6.

PMID:
10995050
10.

State-specific influenza vaccination coverage among adults aged > or =18 years--United States, 2003-04 and 2005-06 influenza seasons.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Sep 21;56(37):953-9.

11.

[Influenza vaccination in Germany. A population-based cross-sectional analysis of three seasons between 2002 and 2005].

Szucs TD, Wahle K, Müller D.

Med Klin (Munich). 2006 Jul 15;101(7):537-45. German.

PMID:
16850169
12.
13.
14.

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

Ryan J, Zoellner Y, Gradl B, Palache B, Medema J.

Vaccine. 2006 Nov 17;24(47-48):6812-22. Epub 2006 Aug 4.

PMID:
17034909
15.

Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age.

Allsup S, Gosney M, Haycox A, Regan M.

Health Technol Assess. 2003;7(24):iii-x, 1-65.

16.

Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons.

Blank PR, Schwenkglenks M, Szucs TD.

Infection. 2009 Oct;37(5):390-400. doi: 10.1007/s15010-009-8467-y. Epub 2009 Sep 18.

PMID:
19768382
17.

[Influence of physician and physician list characteristics on influenza vaccination rates in older people in a health care area in the community of Valencia, Spain].

Schwarz Chávarri H, Pedrera Carbonell V, Ortuño López JL, Orozco Beltrán D, Gil Guillén V, Pastor Climent MA.

Aten Primaria. 2004 Oct 31;34(7):336-42. Spanish.

PMID:
15511353
18.

Using the National Health Interview Survey: time trends in influenza vaccinations among targeted adults.

Pleis JR, Gentleman JF.

Eff Clin Pract. 2002 May-Jun;5(3 Suppl):E3.

PMID:
12166924
19.

Influenza vaccination in paediatric nurses: cross-sectional study of coverage, refusal, and factors in acceptance.

Norton SP, Scheifele DW, Bettinger JA, West RM.

Vaccine. 2008 Jun 2;26(23):2942-8. doi: 10.1016/j.vaccine.2008.03.033. Epub 2008 Apr 8.

PMID:
18448210
20.

One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?

Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL.

Pediatrics. 2006 Jun;117(6):e1070-7.

PMID:
16740809
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk